相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long non-coding RNA SNHG14 exerts oncogenic functions in non-small cell lung cancer through acting as an miR-340 sponge
Zhenhua Zhang et al.
BIOSCIENCE REPORTS (2019)
SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer
Xiufeng Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p
Kai Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer
Pengfei Jiao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ
Nannan Ji et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients
Jun Zhan et al.
THERANOSTICS (2019)
Lung cancer epigenetics: From knowledge to applications
Michael Duruisseaux et al.
SEMINARS IN CANCER BIOLOGY (2018)
The long non-coding RNA SNHG14 inhibits cell proliferation and invasion and promotes apoptosis by sponging miR-92a-3p in glioma
Qiang Wang et al.
Oncotarget (2018)
Role of long non-coding RNA in drug resistance in non-small cell lung cancer
Leirong Wang et al.
THORACIC CANCER (2018)
被撤回的出版物: Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation (Retracted article. See vol. 42, 2023)
Huaying Dong et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer
Hongjing Zang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Uncommon EGFR mutations in advanced non-small cell lung cancer
Grainne M. O'Kane et al.
LUNG CANCER (2017)
The role of microRNAs in the pathophysiology of adrenal tumors
Nunki Hassan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
MicroRNA in cardiovascular biology and disease
Anna Wojciechowska et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)
MiR-488 inhibits proliferation and cisplatin sensibility in non-smallcell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
Chao Fang et al.
SCIENTIFIC REPORTS (2017)
LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
Zheng Fang et al.
CANCER MEDICINE (2017)
Understanding and targeting resistance mechanisms in NSCLC
Julia Rotow et al.
NATURE REVIEWS CANCER (2017)
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
D. A. Fennell et al.
CANCER TREATMENT REVIEWS (2016)
miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression
Xurui Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance
Dong Lan et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2015)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis
Y-R Kim et al.
ONCOGENE (2014)
MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma
Lu-Kai Wang et al.
PLOS ONE (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
Molecular pathways and therapeutic targets in lung cancer
Emma Shtivelman et al.
ONCOTARGET (2014)
Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells
Mei Wang et al.
JOURNAL OF CHEMOTHERAPY (2013)
miR-133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP-14
Meng Xu et al.
ONCOLOGY REPORTS (2013)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
分享论文
